Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Sampling, AQL
Qvents Team
1 minute read
Guidelines
Home
Guidelines
Sampling, AQL
Updated on April 2, 2026
Home
Guidelines
Sampling, AQL
Updated on April 2, 2026
WHO
TRS 929 – Annex 4
:
WHO Guidelines for Sampling of Pharmaceutical Products and Related Materials
ISO 2859-1-1999:
Sampling procedures for inspection by attributes — Part 1: Sampling schemes indexed by acceptance quality limit (AQL) for lot-by-lot inspection
ISO
2859-2:2020 – Sampling procedures for inspection by attributes — Part 2: Sampling plans indexed by limiting quality (LQ) for isolated lot inspection
IPA
: Visual Inspection of Sterile Products – Best Practices Document
Useful Info:
Explaining Acceptance Quality Limit (AQL) for product inspection
– Eurofins Document
Tags :
WHO
Share:
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
USFDA Issues Guidance for Impurity Specifications for Semi-Synthetic & Fermentation Antibiotics
April 21, 2026
Responding to FDA Form 483: USFDA Issues Guidance
April 2, 2026
Qvents Apps and Tools For QMS and GMP Processes
February 17, 2026
Unichem Recalls Hypertension Tablets for Nitrosamine Impurity
February 16, 2026
USFDA 483 to Pharmathen Flags Deficient Aseptic Operations
February 5, 2026
